The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bergmark Richard L since 2006.
The trader's CIK number is 1282546.
At the time of the last reporting, Bergmark Richard L was the EVP, CFO & Treasurer of Core Laboratories N V. (stock ticker symbol CLB).
Also see all insider trading activities at Core Laboratories N V.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | CLB | 0 | $0 | 0 | $0 | 20,000 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | CLB | 0 | $0 | 0 | $0 | 17,685 | $0 |
2016 | CLB | 0 | $0 | 0 | $0 | 16,002 | $0 |
2015 | CLB | 0 | $0 | 0 | $0 | 11,721 | $0 |
2014 | CLB | 0 | $0 | 0 | $0 | 12,587 | $0 |
2014 | CLB | 7,000 | $1,032,717 | 0 | $0 | 13,950 | $0 |
2013 | CLB | 0 | $0 | 20,000 | $2,989,560 | 14,200 | $0 |
2012 | CLB | 0 | $0 | 0 | $0 | 4,200 | $0 |
2011 | CLB | 0 | $0 | 50,000 | $5,593,950 | 4,200 | $0 |
2010 | CLB | 0 | $0 | 35,000 | $4,309,795 | 2,100 | $0 |
2009 | CLB | 0 | $0 | 50,000 | $5,246,755 | 2,100 | $0 |
2008 | CLB | 0 | $0 | 100,000 | $12,648,272 | 2,100 | $0 |
2007 | CLB | 0 | $0 | 164,900 | $14,604,070 | 271,000 | $3,870,450 |
2006 | CLB | 0 | $0 | 12,000 | $857,532 | 116,000 | $804,000 |
2. Core Laboratories N V (CLB)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-01-31 | CLB | Option Ex | 20,000 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-12-29 | CLB | Option Ex | 17,685 | .00 | 0 |
2016-12-30 | CLB | Option Ex | 8,001 | .00 | 0 |
2016-12-30 | CLB | Option Ex | 8,001 | .00 | 0 |
2015-12-31 | CLB | Option Ex | 11,721 | .00 | 0 |
2014-12-31 | CLB | Option Ex | 12,587 | .00 | 0 |
2014-07-28 | CLB | Buy | 7,000 | 147.53 | 1,032,717 |
2013-12-31 | CLB | Option Ex | 13,950 | .00 | 0 |
2013-08-07 | CLB | Sale | 20,000 | 149.48 | 2,989,560 |
2013-03-01 | CLB | Option Ex | 2,200 | .00 | 0 |
2012-12-31 | CLB | Option Ex | 12,000 | .00 | 0 |
2012-05-15 | CLB | Option Ex | 2,000 | .00 | 0 |
2012-03-01 | CLB | Option Ex | 2,200 | .00 | 0 |
2011-07-25 | CLB | Sale | 50,000 | 111.88 | 5,593,950 |
2011-05-15 | CLB | Option Ex | 2,000 | .00 | 0 |
2011-03-01 | CLB | Option Ex | 2,200 | .00 | 0 |
2010-05-15 | CLB | Option Ex | 1,000 | .00 | 0 |
2010-03-01 | CLB | Option Ex | 1,100 | .00 | 0 |
2010-02-17 | CLB | Sale | 35,000 | 123.14 | 4,309,795 |
2009-10-30 | CLB | Sale | 20,481 | 104.93 | 2,149,091 |
2009-11-02 | CLB | Sale | 29,519 | 104.94 | 3,097,664 |
2009-05-15 | CLB | Option Ex | 1,000 | .00 | 0 |
2009-03-01 | CLB | Option Ex | 1,100 | .00 | 0 |
2008-03-01 | CLB | Option Ex | 1,100 | .00 | 0 |
2008-05-15 | CLB | Option Ex | 1,000 | .00 | 0 |
2008-02-27 | CLB | Sale | 26,730 | 126.85 | 3,390,647 |
2008-02-26 | CLB | Sale | 13,750 | 127.34 | 1,750,925 |
2008-02-27 | CLB | Sale | 15,259 | 125.14 | 1,909,587 |
2008-02-27 | CLB | Sale | 44,261 | 126.46 | 5,597,113 |
2007-08-17 | CLB | Sale | 11,625 | 102.84 | 1,195,549 |
2007-08-17 | CLB | Sale | 41,472 | 102.28 | 4,241,714 |
2007-08-17 | CLB | Sale | 11,803 | 101.53 | 1,198,370 |
2007-05-15 | CLB | Option Ex | 1,000 | .00 | 0 |
2007-02-21 | CLB | Option Ex | 270,000 | 14.34 | 3,870,450 |
2007-02-21 | CLB | Sale | 13,600 | 79.22 | 1,077,324 |
2007-02-21 | CLB | Sale | 12,500 | 80.10 | 1,001,212 |
2007-02-21 | CLB | Sale | 37,500 | 79.86 | 2,994,937 |
2007-02-21 | CLB | Sale | 36,400 | 79.53 | 2,894,964 |
2006-08-16 | CLB | Sale | 12,000 | 71.46 | 857,532 |
2006-05-01 | CLB | Option Ex | 96,000 | 8.38 | 804,000 |
2006-01-17 | CLB | Option Ex | 20,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bergmark Richard L (EVP, CFO & Treasurer of Core Laboratories N V at the time of this reporting) see the Securities and Exchange Commission (SEC) website.